Abstract: Conformers generally deviate structurally from their starting X-ray crystal structures early in molecular dynamics (MD) simulations. Studies have recognized such structural differences and attempted to provide an explanation for and justify the necessity of MD equilibrations. However, a detailed explanation based on fundamental physics and validation on a large ensemble of protein structures is still missing. Here we provide the first thermodynamic insights into the radically different thermodynamic conditions of crystallization solutions and conventional MD simulations.
Introduction
Protein conformations are affected by several factors. In fact, the same amino acid linear sequence can, in principle, fold into different tertiary structures. Among these tertiary structures of a protein, the native structure is the protein spatial organization in its functional condition. Environment conditions that allow the protein to stay in its native state are called physiological conditions and the native state corresponds, by definition, to the free energy minimum of the system under those given thermodynamic conditions (e.g., temperature, pressure, solutes, type of solvent and solvent conditions, 1−4 and protein concentrations). The energy landscape of a protein is dynamic, such that its shape and the probabilities of the substate populations are dynamically influenced by several factors. 1−5 It has been proven that even small changes in thermodynamic conditions, such as variation of just a few degrees in temperature and/or an increase in salt concentrations, 5 or different solution thermodynamic conditions can lead to different native protein structures, not to mention the structural changes that are triggered upon ligand binding. 5, 6 or during allosteric interactions.
The relevance of solution conditions is clearly shown when a phase diagram for protein solution is plotted. In the schematic phase diagram shown in Figure 1 , we display in black the spinodal line for the model system. Spinodal lines separate the phase diagrams into two regions of thermodynamic stability of the protein solution. In the schematic phase diagram displayed, under the thermodynamic conditions of the region lying above the spinodal line the free energy minimum of the system (protein solution) corresponds to a single phase, homogeneous protein solution. Conversely, under thermodynamic conditions corresponding to a point below the spinodal line, the free energy minimum is a demixed solution with regions of high protein concentration and low protein concentration elsewhere. This phenomenon, usually known as liquid-liquid demixing (LLD), occurs for a variety of systems including hard spheres or polymers.
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The spinodal represents the boundary of phase transition. On approaching the spinodal from the stability region of the phase diagram (above), the system experiences spontaneous fluctuations in the local concentration of protein with anomalous amplitudes and lifetimes. The amplitude and lifetime of such anomalous fluctuations are governed by only one variable, ε , which is defined as follows:
where T is the system temperature and T S is the corresponding spinodal temperature. In other words, ε is a normalized distance in temperature from the instability region of the phase diagram. 8, 9 A simple mathematical derivation of the laws governing anomalous fluctuation in the case of protein crystallization is given in Pullara et al. 8 Because of the fact that functional proteins are stable in solution, protein physiological conditions have to lie in the regions of the phase diagram where the homogeneous protein solution condition is thermodynamically stable. This case corresponds in Figure 1 to the green cloud in the upper-left region, not too close to the thermodynamic instability region. Under those conditions, the free energy minimum corresponds to the native structure of the protein. In contrast, crystallization conditions usually lie much closer to the spinodal (or instability region of the phase diagram), as schematically shown by the red cloud in Figure 1 . Those thermodynamic conditions drive the precipitation of proteins, otherwise stable in solution, to eventually form crystals/fibers/aggregates.
Before precipitation into crystalline forms, proteins generally undergo a broad range of conformational rearrangements (from minor up to very relevant ones) and those initial variations in the protein structure are required for facilitating the formation of crystal nuclei and their subsequent growth. In addition, in protein crystals, the occurrence of the so-called "crystal contacts" involves strong protein-protein interaction fields that restrict the motions of the parts of the proteins involved in crystal contacts. These constraints may prevent proteins from exploring the full functional conformational space that is otherwise accessible under physiological conditions. From the native structure of proteins to their structure in crystals two different types of conformational changes occur: (i) the first is thermodynamically driven, renders proteins unstable in solution, and is suitable for crystal nuclei formation; (ii) the second is local and facilitated by intermolecular crystal contacts. These are physical contacts between proteins in the crystal arrangement, which induce constraints, if not alterations in interfacial conformations. Such conformational changes depend on the very local chemical and structural features of the proteins where the crystal contacts take place.
In order to quantify and investigate to what extent the above-discussed formation of crystal contacts and nonphysiological conditions during crystallization process alter the protein structure, we performed molecular dynamics (MD) simulations under physiological conditions for a large set of 70 randomly selected different protein crystal structures. After 10 ns of MD simulations the overall fold of the proteins was conserved, but a significantly large average root-mean-square deviation (RMSD) of~2 Å from their crystal structures was observed. The black line represents the spinodal line for the system, which is the boundary for a phase transition. The region above the spinodal line is the thermodynamically stable region for homogeneous protein solution (here only one phase is present for the sake of simplicity); below the spinodal line is the instability region for protein solution. In this region we observe liquid-liquid demixing and formation of subregions that have higher protein concentrations than the remaining; two different phases coexist. The phase transition illustrated in the figure is called "entropy driven". 10 Green and red clouds schematically represent physiological and crystallization conditions, respectively.
Results and discussion

Structures in the Protein Data Bank (PDB)
11 come mainly from X-ray crystallographic studies (88.3%, see http://www.rcsb.org for details) resolved with protein crystallization procedures under extreme environmental conditions that are likely to affect structure on a local scale at least, as discussed in the introduction section. were grown in 20 mM HEPES buffer pH 7.9, 1 mM EDTA, 200 mM NaCl, 1 mM DTT, 10% glycerol, and 0.1% LDAO. Space groups are P 3 2 2 1 and P 2 1 2 1 2 1 for 4HBP and 3QJ8, respectively. The two crystallization buffers differ significantly: 40% PEG 400, 0.1 M sodium acetate pH 4.5 for the first and 20 mM HEPES, pH 7.9, 1 mM EDTA, 200 mM NaCl, 1 mM DTT, 10% glycerol, and 0.1% lauryldimethylamine oxide for the second.
The crystals for the 4HBP were harvested after 7 days and those for the 3QJ8 were harvested after just 3 days after an exchange of buffer to 0.1 M 2-(N-morpholino) ethanesulfonic acid, pH 5.5, 4%-14% PEG 3350, and 50 mM ammonium fluoride. As can be seen in Figure 2B , the B-factor curve of 4HBP has a much higher number of peaks than 3QJ8. The differences in the features of those two curves are amplified in the region of 300-380. As was explained earlier, crystallization conditions are generally very different from physiological conditions. Moreover, differences in crystallization conditions have a significant effect on residue flexibility and dynamics ( Figure 2 ). MD simulations are commonly performed under physiological conditions. In order to quantify the effect of the differences in crystallization and physiological conditions on protein conformations and functions, MD simulations were performed for 43 monomeric and 26 multimeric proteins. A list of these proteins is provided in the Supplementary section (Table S1 ). RMSDs of the newly generated MD conformers from their starting crystal structures were evaluated. To this aim, first all conformers in the MD simulations were aligned with respect to the α -carbon positions of their crystal structures. Once aligned, the C α RMSDs from their crystal structure coordinates were evaluated for the k th MD step as
Here N is the total number of C α atoms, and ⃗ v P DBi and ⃗ v ki are the position vectors of the i th C α atom in the crystal structure and MD conformer. Figure 3A shows the time evolution of these RMSD values averaged over three different categories: (i) all monomers, (ii) all multimers, and (iii) all chains of the multimers treated separately. The drastic increase in RMSDs (up to~0.4 Å) observed during the first 0.1 ns corresponds to the minimization part of MD.
In the subsequent 10 ns of conventional MD (CMD) simulation the change in RMSDs became more subtle with time (gradual increase in the departure from the original structure, as the simulation duration increases), and eventually converged. Strikingly, multimers exhibited significantly larger average RMSDs compared to monomeric proteins. The histograms of the RMSDs collected during the complete MD lengths are presented in Figure 3B, showing that (i) broad ranges of RMSDs were sampled during the minimization and the subsequent 10 ns of CMD simulations, and that (ii) multimers exhibited broader RMSD distributions than monomers. The trajectory average of multimers was~0.5 Å larger than that of single chains. Interestingly, the internal deformations observed for each chain in the multimers (set iii) compared well (scaled) with those observed for monomeric proteins (see Figure 3) , clearly demonstrating that the fluctuation amplitudes of the individual chains are intrinsic properties that are closely maintained in the multimeric structures. Larger RMSDs in multichain proteins essentially arise from interchain movements, while intrachain fluctuations remain practically unaffected by multimerization. This observation also draws attention to the possible sensitivity of multichain/multidomain structures to crystallographic conditions, and the possibility of observing different rearrangements of subunits depending on crystallization conditions.
The crystal structures of proteins correspond to the minima of their free energy surfaces under crystallization conditions but are heavily affected by the presence of many crystal contacts. If MD simulations were to be performed under these crystallization conditions different from physiological conditions, the resulting protein conformer corresponding to the free energy minima would deviate from their crystal structures. This is because, on the one hand, MD has difficulty taking into account crystal contacts and extreme temperatures, and, on the other hand, CMD force fields are optimized around physiological conditions. In the extreme, under crystallization conditions, CMD will not provide an accurate description of the time evolution of protein structures. Interestingly, it happens that changes in RMSDs during the first 2 orders of magnitude in MD simulation time, from 10 −2 ns to 10 0 ns, are qualitatively comparable with those happening in the following 2 orders of magnitude in simulation time, from 10 0 ns to 10 2 ns (see Figure 4) . This behavior suggests that the RMSDs in the first 10 ns of simulation are not simply a result of the equilibrium fluctuations. They may rather be a result of the different thermodynamic conditions of the crystal solution and MD, i.e. the protein is shifting from one free energy surface to another. In the semilog plot, the green and black symbols refer to complement control protein C3 (PDB ID 1G40) and to RNA ∆ 47PolymeraseII (PDB ID 1I3Q), respectively. The first is a single chain protein of 28 kDa (crystallized as a dimer); the second is a ten subunit complex and it weighs~450 kDa. Conformers were aligned and RMSDs were calculated.
Crystal contacts affect the protein structure in two ways: (i) they introduce protein-protein interactions, which are not present under physiological protein concentrations, and (ii) they limit the protein-solvent interactions by decreasing the protein surface exposed to the solvent. In contrast to the crystals, the protein surfaces in our MD simulations were completely exposed to the solvent, hence contributing to the structural deviation from the crystal in the MD simulations. In the literature, extensive experimental and computational studies were performed. 2,3,12−15 on the effect of solvent on protein dynamics and structure.
The solvent-exposed surface was identified by the number of close contact water molecules: water molecules within 2 Å of protein. In Figure 5 we present the correlation between the RMSDs collected at 10 ns and the water-exposed surface area. There are 5 outliers (see the crossed data points in Figure 3 ), two of them (1C44 and 1QVE) falling above the line and 3 of them (1MSP, 1CUN, and 1A4Y) falling below the line. 1C44 is the Sterol Carrier Protein 2 (Scp2) from rabbit and 1QVE is the crystal structure of the truncated K122-4 pilin from Pseudomonas aeruginosa. Both of these structures have unstructured residue stretches on both the N and C terminus, which naturally contributes to the RMSD strongly. 1MSP is the crystal structure of the major sperm protein, alpha isoform (recombinant), while 1CUN is the crystal structure of repeats 16 and 17 of chicken brain alpha spectrin. All of these 3 structures share a common feature: they have rather extended structures that allow them to have a large water contact surface. Except these 5 outliers, the RMSDs from the crystal structures exhibited an approximately linear correlation (Equation y = ax fits the data with a residual of 0.79) with the water-exposed surface, hence strongly supporting the effect of crystal contacts on protein structure. In addition to the 2 Å cutoff used earlier, the solvent-exposed protein surface was also assessed by the number of close contact water molecules within 5 Å of the protein. As shown in Figures 6A and 6B , the number of close contact water molecules within 2 Å and 5 Å both exhibited a linear correlation with the protein size, which was determined by the number of C α atoms. The only data point not following this linear correlation was the ribonuclease inhibitor (PDB ID: 1A4Y). The ribonuclease inhibitor stands out among all the remaining proteins structurally as it exhibits a very packed structure through repeating alpha helices and beta sheets ( Figure 6B ). Considering the correlation between the number of close contact water molecules with both the protein size and the RMSD, it can be concluded that a larger RMSD from the crystal structure should be expected in MD simulations as the protein size increases.
Experimental
MD simulations in NAMD
MD simulations were performed for a broad set of 70 proteins ranging from a size of 95 residues up to 1166
residues and a resolution of 1.15-3 Å (Table S1 ). Each protein was simulated for at least 10 ns, totaling more than 1000 ns of CMD simulations. Structures were solvated in water boxes having at minimum a 10 Å cushion of water in each direction from the exposed atoms. Ions were added to neutralize the systems. Simulations were performed using the NAMD. 16 2.9 package with CHARMM27 force field. 17 A cutoff distance of 12 Å was adopted for van der Waals interactions, with a switching function starting at 10 Å and reaching zero at 12 Å. The particle-mesh Ewald method 18 was used to compute long-range electrostatic forces. The equilibrated structures were generated upon two cycles of minimization-equilibration simulations: the first cycle (minimization and subsequent equilibration simulations) at constant temperature (310 K) and pressure (1 atm) (NPT ensemble) with the C α atoms held fixed and the second cycle at constant T and V (canonical ensemble). Each minimization simulation comprised 20,000 steps of minimization. The first CMDs, for which the proteins were held fixed, were performed for 0.5 ns. A damping coefficient of 0.5 ps −1 was used to maintain isothermal conditions. NPT simulations were performed with Langevin Nosé-Hoover method to keep the pressure constant. 19, 20 Time steps of 1 fs were used in all simulations.
MD simulations in AMBER
Complement control protein C3 (PDB ID 1G40) and RNA ∆47PolymeraseII (PDB ID 1I3Q) structures were solvated in water boxes having at minimum a 10 Å cushion of water in each direction from the exposed atoms. Ions were added to neutralize the systems. The simulation box was built with explicit water using TLEAP from AMBERTOOLS 12. Simulations were performed using AMBER 12.
21 For both systems the protocol consists of standard four steps: 1) minimization: PDB is checked for possible overlap of loops; 2) heating: 0.1 ns of heating up to 298 K; 3) equilibration: 1 ns at 298 K; 4) production: 100 ns of free simulation. A cutoff distance of 12 Å was adopted for van der Waals interactions, with a switching function starting at 10 Å and reaching zero at 12 Å. The particle-mesh Ewald method was used to compute long-range electrostatic forces.
Conclusion
In this study we have described for the first time how different the thermodynamic conditions of the crystallization solutions and those of MD simulations (performed under physiological conditions) are. MD simulations of even short durations showed that the protein structures deviate from their original PDB coordinates, in particular multimers deviating more than monomers. For multimers two types of deviations were observed:
(i) interchain and (ii) intrachain. Interestingly, the interchain deformations appear not to depend on whether the structure is single-or multichain, which indicates that the larger RMSD in multichain/multimeric proteins essentially arises from interchain movements, while intrachain fluctuations remain practically unaffected by multimerization. A possible explanation for the latter is that, in the presence of crystal contacts, monomers act as though they were a part of a multimeric structure, i.e. the crystal packing mimics intrachain interactions of multimeric structures. The observed structural deviations from crystals in MD simulations are not completely due to the thermodynamic conditional differences between crystal solutions and MD simulations. Several sources of errors in MD also contribute to the structural differences between MD conformers and their crystal structures. One source of error in MD is that Newton's equations of motion are not solved exactly. Instead, numerical methods are applied, which give rather approximate solutions. The force fields used to estimate the potential energy are another source of error. In these force fields mathematical functions are utilized to model interactions, some of these functions being crude approximations. Moreover, the parameters of these functions are derived from quantum mechanics and experimental data, which are susceptible to being sources of errors since they include numerous approximation and different types of experiments.
Crystal packing can also alter the protein dynamics and residue motions. 
